Cite
HARVARD Citation
Claudiani, S. et al. (2022). Durable humoral responses after the second anti‐SARS‐CoV‐2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors. British journal of haematology. pp. e1-e4. [Online].